Skip to main content
. 2014 Mar 19;9(3):e92627. doi: 10.1371/journal.pone.0092627

Figure 1. Cell viability of B16F10 cells after treatment with melatonin with or without thapsigargin or tunicamycin.

Figure 1

Cell survival of B16F10 cells was determined after 24± SD of three experiments. *P<0.05; **P<0.01; ***P<0.001 vs. untreated control; ### P<0.001, melatonin vs. melatonin with thapsigargin or tunicamycin.